Current Portfolio
Illuminoss
Dutch clinical stage biopharmaceutical company developing a treatment for acute kidney injury.
Key Facts
- Sector
Life Sciences
- Country
United States
- Fund
LSP HEF 1
- Entry
2012
Website
Do You Want to Know More?
We are eager to explore how we can achieve great things together.